New study counts how many preemies get eylea for blinding eye condition
NCT ID NCT06315556
First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 31 times
Summary
This study looks at how often preterm babies with retinopathy of prematurity (ROP) receive the medicine Eylea using a special pediatric dosing device in the UK. Researchers will collect data from a national database on up to 200 babies born between 2024 and 2026. The goal is to see if enough babies are treated to later study the long-term safety of this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRETERM INFANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many locations
RECRUITINGMultiple Locations, United Kingdom
Conditions
Explore the condition pages connected to this study.